(6aR,9R)-N,N-diethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide结构式
|
常用名 | (6aR,9R)-N,N-diethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide | 英文名 | (6aR,9R)-N,N-diethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide |
|---|---|---|---|---|
| CAS号 | 35779-43-2 | 分子量 | 309.40500 | |
| 密度 | 1.23 g/cm3 | 沸点 | 550ºC at 760 mmHg | |
| 分子式 | C19H23N3O | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS06 |
信号词 | Danger |
| 英文名 | (6aR,9R)-N,N-diethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide |
|---|---|
| 英文别名 | 更多 |
| 密度 | 1.23 g/cm3 |
|---|---|
| 沸点 | 550ºC at 760 mmHg |
| 分子式 | C19H23N3O |
| 分子量 | 309.40500 |
| 精确质量 | 309.18400 |
| PSA | 48.13000 |
| LogP | 2.89260 |
| 折射率 | 1.657 |
| 符号 |
GHS06 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H301-H311-H331 |
| 警示性声明 | P261-P280-P301 + P310-P311 |
| 个人防护装备 | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| 危害码 (欧洲) | T: Toxic; |
| 风险声明 (欧洲) | R23/24/25 |
| 安全声明 (欧洲) | 36/37/39-45 |
| 危险品运输编码 | UN 2811 6 |
| 海关编码 | 2933990090 |
|
~67%
(6aR,9R)-N,N-di... 35779-43-2 |
| 文献:Zhang, Fang-Jie; Liu, Hshiou-ting Patent: US2006/223998 A1, 2006 ; Location in patent: Page/Page column 2; sheet 3 ; |
|
~59%
(6aR,9R)-N,N-di... 35779-43-2 |
| 文献:Hoffman; Nichols Journal of Medicinal Chemistry, 1985 , vol. 28, # 9 p. 1252 - 1255 |
|
~%
(6aR,9R)-N,N-di... 35779-43-2 |
| 文献:Stachulski, Andrew V.; Nichols, David E.; Scheinmann, Feodor Journal of Chemical Research - Part S, 1996 , # 1 p. 30 - 31 |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Quantification of LSD and N-demethyl-LSD in urine by gas chromatography/resonance electron capture ionization mass spectrometry.
Anal. Chem. 60(14) , 1420-5, (1988)
|
|
|
Determination of LSD and N-demethyl-LSD in urine by liquid chromatography coupled to electrospray ionization mass spectrometry.
J. Chromatogr. B. Biomed. Sci. Appl. 692(2) , 329-35, (1997) A sensitive and highly specific method for the determination of LSD and N-demethyl-LSD in urine, using combined liquid chromatography and mass spectrometry (LC-MS) with electrospray ionization, has be... |
|
|
Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
J. Forensic Sci. 43(3) , 622-5, (1998) A forensic procedure for the quantitative confirmation of lysergic acid diethylamide (LSD) and the qualitative confirmation of its metabolite, N-demethyl-LSD, in blood, serum, plasma, and urine sample... |
| N-Demethyl-LSD |
| 6-norlysergic |
| N-Demthyl-lsd |
| N-Demethyllysergic acid diethylamide |
| 6-Norlysergic acid diethylamide |
| 9,10-didehydro-ergoline-8-carboxylic acid diethylamide |
| nor-lysergic acid diethylamide |
| BIDD:GT0518 |